Related Experiment Video
Updated: Jul 5, 2025
10:34
Measurement of Differentially Methylated INS DNA Species in Human Serum Samples as a Biomarker of Islet β Cell Death
Published on: December 21, 2016
6.4K
DNA Methylation-Based Assessment of Cell Composition in Human Pancreas and Islets
Zeina Drawshy1, Daniel Neiman1, Ori Fridlich1
1Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada (IMRIC), Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Diabetes
|January 24, 2024
Summary
This study introduces DNA methylation markers to accurately measure pancreas cell types, crucial for understanding diabetes. This novel method reveals insights into beta-cell function and cell composition in various diabetes types.
Area of Science:
- Endocrinology and Metabolism
- Molecular Biology
- Genomics
Background:
- Accurate assessment of pancreas cell type composition is vital for understanding diabetes development.
- Current methods relying on protein markers like insulin have limitations due to variable protein content in physiological and pathological states.
- Existing techniques complicate the accurate determination of actual cell numbers, impacting diabetes research.
Purpose of the Study:
- To develop and validate cell type-specific DNA methylation markers for quantifying pancreatic cell fractions in human tissues.
- To assess beta-cell function and cell composition in pre-type 1 diabetes (T1D), T1D, and type 2 diabetes (T2D) using methylation analysis.
- To provide a molecular alternative to immunodetection for analyzing pancreas cell types in health and disease.
Main Methods:
- Identification of unique DNA methylation loci for specific pancreatic cell types (e.g., alpha and beta cells).
- Application of targeted PCR to assess methylation status in human islet and pancreas specimens.
- Normalization of insulin secretion to beta-cell DNA fraction to evaluate beta-cell function.
Main Results:
- Methylation-based analysis accurately determines pancreatic cell type composition, overcoming limitations of protein-based methods.
- Beta-cell function, normalized to beta-cell DNA, was similarly reduced in pre-T1D, T1D, and T2D compared to non-diabetic donors.
- Recent-onset T1D showed normal beta-cell fraction, suggesting dysfunction, while T2D exhibited increased alpha-cell fraction and normal beta-cell fraction.
Conclusions:
- DNA methylation markers offer a precise molecular method for assessing human pancreas cell composition, superior to traditional immunodetection.
- This approach provides valuable insights into beta-cell function and cell type alterations in various diabetes mellitus types.
- Methylation-based analysis is a powerful tool for interpreting insulin secretion assays and advancing diabetes research.
